Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Mackler

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Oncology Practice|January 4, 2018
Oncology Pharmacist Opportunities: Closing the Gap in Quality CareVera Vulaj, Shannon Hough, Louise Bedard, et al.
Journal of Oncology Practice|March 13, 2019
2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice StandardEmily Mackler, Eve M Segal, Benyam Muluneh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2010
Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patientsShawna Kraft, Emily Mackler, Peter Schlickman, et al.
Journal of the American Pharmacists Association : Japha|September 12, 2015
Evaluation of outpatient medication reconciliation involving student pharmacists at a comprehensive cancer centerEmily Ashjian, Louise B Salamin, Katie Eschenburg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 27, 2012
Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patientsShawna Kraft, Emily Mackler, Peter Schlickman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 19, 2024
Key Performance Indicators and Metrics for the Implementation of an Oral Chemotherapy Adherence ProgramBenyam Muluneh, James B Collins, Brian Lam, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 20, 2026
Assessment of alpelisib-induced hyperglycemia in a real-world setting: A nationwide claims data analysisMohamad Ismail, Jun Gong, Vincent D Marshall, et al.
JCO Clinical Cancer Informatics|May 18, 2019
Clinician Report of Oral Oncolytic Symptoms and Adherence Obtained via a Patient-Reported Outcome Measure (PROM)Victoria R Nachar, Karen Farris, Katie Beekman, et al.
Exploratory Research in Clinical and Social Pharmacy|August 12, 2022
Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA)Karen B Farris, Tiffany Cadwallader, Joel Farley, et al.
Journal of Oncology Practice|August 18, 2016
Improving Oral Oncolytic Patient Self-ManagementElaine McNamara, Lindsey Redoutey, Emily Mackler, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Oncology Practice|January 4, 2018
Oncology Pharmacist Opportunities: Closing the Gap in Quality CareVera Vulaj, Shannon Hough, Louise Bedard, et al.
Journal of Oncology Practice|March 13, 2019
2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice StandardEmily Mackler, Eve M Segal, Benyam Muluneh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2010
Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patientsShawna Kraft, Emily Mackler, Peter Schlickman, et al.
Journal of the American Pharmacists Association : Japha|September 12, 2015
Evaluation of outpatient medication reconciliation involving student pharmacists at a comprehensive cancer centerEmily Ashjian, Louise B Salamin, Katie Eschenburg, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 27, 2012
Outcomes of therapy vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patientsShawna Kraft, Emily Mackler, Peter Schlickman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 19, 2024
Key Performance Indicators and Metrics for the Implementation of an Oral Chemotherapy Adherence ProgramBenyam Muluneh, James B Collins, Brian Lam, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 20, 2026
Assessment of alpelisib-induced hyperglycemia in a real-world setting: A nationwide claims data analysisMohamad Ismail, Jun Gong, Vincent D Marshall, et al.
JCO Clinical Cancer Informatics|May 18, 2019
Clinician Report of Oral Oncolytic Symptoms and Adherence Obtained via a Patient-Reported Outcome Measure (PROM)Victoria R Nachar, Karen Farris, Katie Beekman, et al.
Exploratory Research in Clinical and Social Pharmacy|August 12, 2022
Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA)Karen B Farris, Tiffany Cadwallader, Joel Farley, et al.
Journal of Oncology Practice|August 18, 2016
Improving Oral Oncolytic Patient Self-ManagementElaine McNamara, Lindsey Redoutey, Emily Mackler, et al.
Pageof 3